Annual report pursuant to Section 13 and 15(d)

Consolidated Balance Sheets

v3.8.0.1
Consolidated Balance Sheets - USD ($)
Jun. 30, 2017
Jun. 30, 2016
Current assets:    
Cash $ 14,326 $ 5,481
Accounts receivable (net of allowance of $0 and $22,681, respectively) 382 1,358
Inventories 95,865 121,706
Other current assets 3,491 1,400
Total current assets 114,064 129,945
Total assets 114,064 129,945
Current liabilities:    
Accounts payable 205,961 165,441
Accrued expense-related party 180,000 108,000
Convertible notes payable-net of debt discounts and unamortized beneficial conversion feature 151,020
Fair value of derivative liabilities 44,022
Short-term borrowings 3,096 4,290
Advance-related party 1,000
Advance from Shareholders 995 23,000
Total current liabilities 585,094 301,731
Long term borrowings 2,222
Commitments and contingencies
Stockholders' deficit:    
Common stock, ($0.001 par value, 100,000,000 shares authorized, and 29,724,432 issued and outstanding as of June 30, 2017 and 28,501,932 outstanding as of June 30, 2016, respectively) 29,724 28,502
Additional paid in capital 2,880,467 2,263,294
Accumulated deficit (3,381,221) (2,465,804)
Total stockholders' deficit (471,030) (174,008)
Total Liabilities and Stockholders' Deficit $ 114,064 $ 129,945